AlTorress

DRIO, MACD Histogram just turned negative

Short
NASDAQ:DRIO   DarioHealth Corp.
This is a Bearish indicator signaling DRIO's price could decline from here. Traders may explore shorting the stock or put options. Tickeron's A.I.dvisor identified 51 similar cases where DRIO's MACD histogram became negative, and 42 of them led to successful outcomes. Odds of Success: 82%. Current price $27.65 is above $20.20 the highest resistance line found by Tickeron A.I. Throughout the month of 01/15/21 - 02/18/21, the price experienced a +51% Uptrend, while the week of 02/10/21 - 02/18/21 shows a -7% Downtrend.

Bearish Trend Analysis
The Stochastic Indicator may be shifting from an upward trend to a downward trend. Tickeron A.I. detetcted that in 36 of 39 cases where DRIO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for DRIO turned negative on February 18, 2021. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 42 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

DRIO broke above its upper Bollinger Band on February 08, 2021. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.